CN Stock MarketDetailed Quotes

000623 Jilin Aodong Pharmaceutical Group

Watchlist
  • 18.31
  • -0.58-3.07%
Market Closed Nov 15 15:00 CST
21.90BMarket Cap15.31P/E (TTM)

Jilin Aodong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-31.78%1.27B
4.59%2.03B
46.35%1.63B
19.59%1.72B
23.31%1.86B
50.98%1.94B
-32.33%1.12B
-17.46%1.44B
-8.68%1.51B
-13.30%1.28B
Transactional financial assets
-3.60%1.7B
-29.22%1.23B
-15.42%1.45B
1.11%1.66B
16.89%1.76B
-5.89%1.74B
-10.46%1.71B
-25.08%1.64B
-41.01%1.51B
-16.81%1.85B
Notes receivable and accounts receivable
-9.48%971.58M
19.16%1.11B
35.87%1.32B
30.07%1.01B
22.24%1.07B
12.01%932.33M
20.33%971.68M
26.36%776.64M
-3.14%878.02M
-0.09%832.38M
-Notes receivable
--154.5K
-93.04%316.78K
-99.91%101.15K
----
----
--4.55M
--111.78M
--88.13M
----
----
-Accounts receivable
-9.49%971.43M
19.71%1.11B
53.51%1.32B
46.72%1.01B
22.24%1.07B
11.46%927.78M
6.49%859.9M
12.02%688.51M
31.97%878.02M
23.53%832.38M
Other receivables (including interest and dividends)
-36.51%30.56M
-10.64%525.95M
-37.90%39.01M
-50.28%29.98M
-34.95%48.13M
-22.21%588.6M
-21.75%62.82M
-12.00%60.31M
-11.54%73.99M
8.82%756.63M
-Dividend receivable
----
-6.07%494.05M
--555.84K
----
--9.6M
-23.56%526M
----
----
----
11.11%688.15M
-Accrued interest receivable
----
----
----
----
----
----
-18.43%12.67M
2.44%11.84M
14.93%8.59M
18.42%4.02M
-Other receivable
----
-49.04%31.89M
----
----
----
-2.90%62.59M
----
-14.93%48.46M
----
-11.21%64.47M
Advance payment
-6.12%87.06M
-19.73%77.97M
-57.33%60.21M
-60.82%43.38M
-18.52%92.73M
-25.10%97.13M
152.50%141.12M
240.69%110.72M
136.27%113.81M
200.70%129.68M
Inventories
8.06%1.01B
6.88%972.31M
0.76%889.09M
-0.25%872.35M
18.22%932.33M
21.96%909.74M
41.31%882.34M
47.76%874.57M
25.93%788.66M
21.68%745.94M
Receivable financing
-53.15%210.62M
-67.68%150.23M
-36.88%147.59M
41.94%396.77M
160.59%449.55M
121.79%464.79M
-41.77%233.82M
-20.07%279.54M
--172.52M
--209.57M
Non-current assets due within one year
----
----
----
----
----
----
----
----
--10M
--10M
Other current assets
32.51%18.64M
321.30%18.32M
-97.69%18.37M
-98.23%14.17M
-98.23%14.07M
-99.46%4.35M
11.10%795.88M
10.27%801.97M
9.05%795.28M
9.36%798.44M
Total current assets
-15.06%5.29B
-8.40%6.12B
-6.09%5.55B
-3.96%5.75B
6.56%6.23B
0.91%6.68B
-5.45%5.91B
-5.44%5.98B
-11.41%5.85B
-0.04%6.62B
Non Current assets
Other equity investment
-22.03%305.6M
-20.66%312.6M
-14.25%338.61M
-12.16%338.99M
-4.18%391.93M
-21.31%393.98M
-24.67%394.88M
-27.06%385.9M
-18.81%409.03M
1.19%500.65M
Investment real estate
-14.28%22.45M
-5.67%22.95M
3.26%25.47M
3.30%25.83M
-8.59%26.19M
-16.15%24.33M
-16.05%24.67M
-13.16%25.01M
0.61%28.65M
1.43%29.02M
Long-term equity investment
7.09%23.72B
6.15%23.32B
5.33%23.1B
5.39%22.66B
8.74%22.15B
14.69%21.97B
13.74%21.93B
12.54%21.5B
8.96%20.37B
5.39%19.16B
Fixed assets
----
0.07%2.11B
----
----
----
5.18%2.11B
----
2.93%2.11B
----
-2.80%2B
Constru in process
----
130.10%415.82M
----
----
----
-7.08%180.72M
----
-1.09%177.36M
----
67.88%194.48M
Productive biological assets
-16.14%5.47M
-17.34%5.62M
-17.10%5.98M
-21.19%6.04M
-21.10%6.53M
-18.48%6.8M
-17.99%7.21M
-15.85%7.66M
-15.41%8.27M
-16.83%8.34M
Intangible assets
32.11%452.69M
31.14%457.98M
26.39%464.53M
19.25%435.35M
-7.71%342.67M
-7.63%349.23M
-1.04%367.54M
1.52%365.08M
1.19%371.29M
12.69%378.09M
Development expenditure
-41.28%137.77M
-41.80%133.45M
-41.90%124.88M
-20.61%155.71M
31.43%234.63M
33.95%229.29M
29.00%214.93M
14.16%196.14M
31.60%178.52M
33.79%171.18M
Long deferred expense
-50.43%6.76M
-49.86%7.22M
-51.33%7.28M
-48.79%8.25M
-15.86%13.64M
-4.15%14.4M
-4.66%14.95M
-0.67%16.11M
17.87%16.21M
4.57%15.03M
Deferred tax assets
8.20%300.97M
42.01%393.45M
21.40%348M
2.22%309.84M
-14.84%278.15M
3.76%277.06M
25.49%286.66M
84.53%303.12M
210.09%326.62M
92.02%267M
Usufruct assets
8.34%50.29M
-1.34%48.45M
-14.78%44.47M
2.53%47.39M
-7.13%46.42M
-11.82%49.11M
-7.17%52.18M
-22.77%46.23M
-5.89%49.98M
6.84%55.69M
Other non current assets
-48.48%82.22M
21.92%79.97M
42.73%79.13M
-22.95%49.94M
42.19%159.59M
-25.59%65.59M
-35.45%55.44M
-4.30%64.82M
-7.03%112.24M
-20.10%88.15M
Total non current assets
6.43%27.6B
6.39%27.31B
5.43%27.01B
5.24%26.52B
7.78%25.94B
12.25%25.67B
11.52%25.62B
10.81%25.2B
8.47%24.07B
5.54%22.87B
Total assets
2.26%32.9B
3.34%33.42B
3.27%32.56B
3.48%32.27B
7.54%32.17B
9.70%32.34B
7.89%31.53B
7.27%31.18B
3.91%29.91B
4.24%29.48B
Liabilities
Current liabilities
Short term loan
46.23%1.14B
39.27%1.12B
138.07%1.67B
4.15%678.31M
33.89%778.17M
64.33%803.78M
53.86%700.95M
83.19%651.27M
63.25%581.22M
30.83%489.11M
Notes payable and accounts payable
3.87%427.01M
6.34%443.4M
-27.78%297.79M
-7.18%418.59M
18.22%411.1M
4.85%416.98M
40.82%412.35M
89.31%450.97M
36.38%347.75M
46.98%397.68M
-Notes payable
-69.87%3.89M
-8.58%9.65M
-74.13%3.04M
-58.59%5.86M
-9.43%12.92M
-30.80%10.55M
-19.43%11.76M
-20.51%14.16M
-11.04%14.27M
38.68%15.25M
-Accounts payable
6.27%423.12M
6.72%433.75M
-26.42%294.75M
-5.51%412.72M
19.40%398.17M
6.28%406.43M
43.99%400.58M
98.19%436.81M
39.56%333.47M
47.33%382.43M
Contract liabilities
102.08%38.93M
37.61%28.9M
43.07%29.92M
-68.08%26.26M
9.95%19.26M
1.84%21M
39.03%20.91M
348.09%82.25M
-29.29%17.52M
-11.52%20.62M
Advance receipts
7.03%1.87M
-7.07%1.1M
-96.72%959.68K
-96.52%1.01M
-94.02%1.75M
-95.96%1.19M
-19.78%29.29M
-21.06%29.02M
1,836.34%29.18M
1,014.97%29.39M
Salaries payable
-4.56%31.62M
-22.64%32.04M
-14.92%65.06M
-31.43%74.49M
-4.99%33.14M
60.95%41.42M
7.25%76.46M
28.54%108.63M
-11.04%34.88M
-39.68%25.73M
Taxs payable
-59.30%22.45M
-57.59%14.82M
-7.47%40.58M
20.81%67.08M
2.27%55.16M
-19.51%34.93M
-21.17%43.85M
76.25%55.53M
75.81%53.93M
50.98%43.4M
Other payable (including interest and dividends)
-19.82%670.85M
26.94%1.46B
29.97%947.38M
7.09%866.16M
26.11%836.68M
74.20%1.15B
11.15%728.93M
21.96%808.79M
8.82%663.45M
-24.55%658.32M
-Interest payable
-42.58%15.25M
-52.43%6.88M
-79.94%501.11K
20.74%37.45M
24.55%26.55M
24.61%14.46M
24.62%2.5M
99.93%31.01M
100.03%21.32M
100.00%11.61M
-Dividend payable
12,735.28%665.7K
112.23%717.54M
0.00%5.19K
0.00%5.19K
0.00%5.19K
6,518,590.16%338.09M
0.00%5.19K
0.00%5.19K
0.00%5.19K
-100.00%5.19K
-Other payable
-19.16%654.94M
-7.92%731.37M
30.35%946.87M
6.55%828.71M
26.16%810.12M
22.82%794.26M
11.11%726.43M
20.10%777.77M
7.20%642.12M
1.21%646.71M
Non current liabilities due within one year
-99.06%22.42M
-99.11%20.96M
-99.22%18.24M
12,691.29%2.33B
13,206.92%2.38B
11,655.86%2.37B
11,102.90%2.35B
-28.24%18.23M
-18.92%17.91M
-10.58%20.13M
Other current liabilities
101.56%4.83M
15,355.26%403.62M
15,128.22%403.72M
-69.32%3.27M
5.49%2.39M
-2.07%2.61M
37.79%2.65M
366.16%10.67M
-23.22%2.27M
-5.01%2.67M
Total current liabilities
-47.85%2.36B
-27.20%3.52B
-20.40%3.47B
101.67%4.47B
158.63%4.52B
186.60%4.84B
171.72%4.36B
52.18%2.22B
30.27%1.75B
2.89%1.69B
Current liabilities
Bonds payable
--994.72M
--994.23M
----
----
----
----
----
4.15%2.3B
4.39%2.28B
4.60%2.26B
Deferred tax liabilities
138.92%30.64M
80.43%29.38M
65.50%29.13M
15.26%30.03M
104.64%12.82M
-20.23%16.28M
-21.36%17.6M
7.65%26.06M
-88.13%6.27M
46.84%20.41M
Long term deferred income
-16.04%229.48M
-11.93%234.84M
-13.06%240.7M
-12.15%247.38M
-5.81%273.33M
-10.59%266.65M
-8.10%276.87M
-10.28%281.6M
-4.75%290.19M
-8.05%298.24M
Lease liabilities
2.85%22.97M
5.68%21.82M
-8.83%19.15M
22.45%21.49M
9.03%22.34M
-19.05%20.65M
-17.18%21.01M
-24.94%17.55M
-5.68%20.48M
14.52%25.51M
Total non current liabilities
314.22%1.28B
321.72%1.28B
-8.40%288.99M
-88.63%298.9M
-88.13%308.49M
-88.34%303.59M
-87.80%315.48M
2.16%2.63B
1.29%2.6B
3.27%2.6B
Total liabilities
-24.72%3.64B
-6.58%4.8B
-19.60%3.76B
-1.60%4.77B
11.12%4.83B
19.78%5.14B
11.63%4.68B
20.24%4.84B
11.25%4.35B
3.12%4.29B
Shareholders equity
Paid-in capital
2.81%1.2B
2.82%1.2B
6.70%1.24B
0.46%1.17B
0.01%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
Other equity instruments
----
----
----
-3.14%542.29M
-0.07%559.65M
-0.04%559.85M
-0.03%559.86M
-0.03%559.87M
-0.00%560.05M
-0.00%560.05M
Capital reserve funds
22.82%4.85B
22.90%4.85B
40.12%5.53B
2.24%4.03B
0.13%3.95B
0.16%3.95B
-0.84%3.95B
-0.84%3.95B
-0.74%3.94B
-0.84%3.94B
Surplus reserve funds
5.79%2.49B
5.80%2.49B
5.80%2.49B
5.80%2.49B
8.03%2.35B
8.29%2.35B
8.33%2.35B
8.33%2.35B
10.53%2.18B
10.26%2.17B
Retained profit
3.01%19.91B
0.45%19.2B
3.44%19.53B
5.41%19.38B
9.41%19.33B
10.94%19.12B
10.19%18.88B
7.71%18.39B
2.79%17.67B
4.72%17.23B
Less:Treasury stock
----
----
26.31%720.07M
26.31%720.07M
12.72%620.05M
26.85%570.07M
42.51%570.07M
42.51%570.07M
37.50%550.06M
12.34%449.41M
Other composite income
80.89%553.58M
79.98%617M
113.93%455.99M
62.35%314.7M
-4.15%306.04M
14.31%342.81M
-14.94%213.15M
-38.08%193.84M
30.81%319.28M
37.29%299.91M
Shareholders equity without minority interests
7.25%29B
5.37%28.36B
7.46%28.52B
4.52%27.21B
6.96%27.04B
8.00%26.91B
6.78%26.54B
4.72%26.03B
2.36%25.28B
4.08%24.92B
Minority interests
-12.54%261.78M
-8.69%268.67M
-10.13%277M
-5.12%288.01M
4.31%299.3M
6.66%294.25M
76.18%308.22M
69.33%303.54M
56.94%286.95M
49.15%275.88M
Total shareholder equity
7.03%29.26B
5.21%28.62B
7.26%28.8B
4.41%27.5B
6.93%27.34B
7.98%27.21B
7.27%26.85B
5.19%26.34B
2.76%25.57B
4.43%25.19B
Total liabilityies and equity
2.26%32.9B
3.34%33.42B
3.27%32.56B
3.48%32.27B
7.54%32.17B
9.70%32.34B
7.89%31.53B
7.27%31.18B
3.91%29.91B
4.24%29.48B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhongzhun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongzhun Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -31.78%1.27B4.59%2.03B46.35%1.63B19.59%1.72B23.31%1.86B50.98%1.94B-32.33%1.12B-17.46%1.44B-8.68%1.51B-13.30%1.28B
Transactional financial assets -3.60%1.7B-29.22%1.23B-15.42%1.45B1.11%1.66B16.89%1.76B-5.89%1.74B-10.46%1.71B-25.08%1.64B-41.01%1.51B-16.81%1.85B
Notes receivable and accounts receivable -9.48%971.58M19.16%1.11B35.87%1.32B30.07%1.01B22.24%1.07B12.01%932.33M20.33%971.68M26.36%776.64M-3.14%878.02M-0.09%832.38M
-Notes receivable --154.5K-93.04%316.78K-99.91%101.15K----------4.55M--111.78M--88.13M--------
-Accounts receivable -9.49%971.43M19.71%1.11B53.51%1.32B46.72%1.01B22.24%1.07B11.46%927.78M6.49%859.9M12.02%688.51M31.97%878.02M23.53%832.38M
Other receivables (including interest and dividends) -36.51%30.56M-10.64%525.95M-37.90%39.01M-50.28%29.98M-34.95%48.13M-22.21%588.6M-21.75%62.82M-12.00%60.31M-11.54%73.99M8.82%756.63M
-Dividend receivable -----6.07%494.05M--555.84K------9.6M-23.56%526M------------11.11%688.15M
-Accrued interest receivable -------------------------18.43%12.67M2.44%11.84M14.93%8.59M18.42%4.02M
-Other receivable -----49.04%31.89M-------------2.90%62.59M-----14.93%48.46M-----11.21%64.47M
Advance payment -6.12%87.06M-19.73%77.97M-57.33%60.21M-60.82%43.38M-18.52%92.73M-25.10%97.13M152.50%141.12M240.69%110.72M136.27%113.81M200.70%129.68M
Inventories 8.06%1.01B6.88%972.31M0.76%889.09M-0.25%872.35M18.22%932.33M21.96%909.74M41.31%882.34M47.76%874.57M25.93%788.66M21.68%745.94M
Receivable financing -53.15%210.62M-67.68%150.23M-36.88%147.59M41.94%396.77M160.59%449.55M121.79%464.79M-41.77%233.82M-20.07%279.54M--172.52M--209.57M
Non-current assets due within one year ----------------------------------10M--10M
Other current assets 32.51%18.64M321.30%18.32M-97.69%18.37M-98.23%14.17M-98.23%14.07M-99.46%4.35M11.10%795.88M10.27%801.97M9.05%795.28M9.36%798.44M
Total current assets -15.06%5.29B-8.40%6.12B-6.09%5.55B-3.96%5.75B6.56%6.23B0.91%6.68B-5.45%5.91B-5.44%5.98B-11.41%5.85B-0.04%6.62B
Non Current assets
Other equity investment -22.03%305.6M-20.66%312.6M-14.25%338.61M-12.16%338.99M-4.18%391.93M-21.31%393.98M-24.67%394.88M-27.06%385.9M-18.81%409.03M1.19%500.65M
Investment real estate -14.28%22.45M-5.67%22.95M3.26%25.47M3.30%25.83M-8.59%26.19M-16.15%24.33M-16.05%24.67M-13.16%25.01M0.61%28.65M1.43%29.02M
Long-term equity investment 7.09%23.72B6.15%23.32B5.33%23.1B5.39%22.66B8.74%22.15B14.69%21.97B13.74%21.93B12.54%21.5B8.96%20.37B5.39%19.16B
Fixed assets ----0.07%2.11B------------5.18%2.11B----2.93%2.11B-----2.80%2B
Constru in process ----130.10%415.82M-------------7.08%180.72M-----1.09%177.36M----67.88%194.48M
Productive biological assets -16.14%5.47M-17.34%5.62M-17.10%5.98M-21.19%6.04M-21.10%6.53M-18.48%6.8M-17.99%7.21M-15.85%7.66M-15.41%8.27M-16.83%8.34M
Intangible assets 32.11%452.69M31.14%457.98M26.39%464.53M19.25%435.35M-7.71%342.67M-7.63%349.23M-1.04%367.54M1.52%365.08M1.19%371.29M12.69%378.09M
Development expenditure -41.28%137.77M-41.80%133.45M-41.90%124.88M-20.61%155.71M31.43%234.63M33.95%229.29M29.00%214.93M14.16%196.14M31.60%178.52M33.79%171.18M
Long deferred expense -50.43%6.76M-49.86%7.22M-51.33%7.28M-48.79%8.25M-15.86%13.64M-4.15%14.4M-4.66%14.95M-0.67%16.11M17.87%16.21M4.57%15.03M
Deferred tax assets 8.20%300.97M42.01%393.45M21.40%348M2.22%309.84M-14.84%278.15M3.76%277.06M25.49%286.66M84.53%303.12M210.09%326.62M92.02%267M
Usufruct assets 8.34%50.29M-1.34%48.45M-14.78%44.47M2.53%47.39M-7.13%46.42M-11.82%49.11M-7.17%52.18M-22.77%46.23M-5.89%49.98M6.84%55.69M
Other non current assets -48.48%82.22M21.92%79.97M42.73%79.13M-22.95%49.94M42.19%159.59M-25.59%65.59M-35.45%55.44M-4.30%64.82M-7.03%112.24M-20.10%88.15M
Total non current assets 6.43%27.6B6.39%27.31B5.43%27.01B5.24%26.52B7.78%25.94B12.25%25.67B11.52%25.62B10.81%25.2B8.47%24.07B5.54%22.87B
Total assets 2.26%32.9B3.34%33.42B3.27%32.56B3.48%32.27B7.54%32.17B9.70%32.34B7.89%31.53B7.27%31.18B3.91%29.91B4.24%29.48B
Liabilities
Current liabilities
Short term loan 46.23%1.14B39.27%1.12B138.07%1.67B4.15%678.31M33.89%778.17M64.33%803.78M53.86%700.95M83.19%651.27M63.25%581.22M30.83%489.11M
Notes payable and accounts payable 3.87%427.01M6.34%443.4M-27.78%297.79M-7.18%418.59M18.22%411.1M4.85%416.98M40.82%412.35M89.31%450.97M36.38%347.75M46.98%397.68M
-Notes payable -69.87%3.89M-8.58%9.65M-74.13%3.04M-58.59%5.86M-9.43%12.92M-30.80%10.55M-19.43%11.76M-20.51%14.16M-11.04%14.27M38.68%15.25M
-Accounts payable 6.27%423.12M6.72%433.75M-26.42%294.75M-5.51%412.72M19.40%398.17M6.28%406.43M43.99%400.58M98.19%436.81M39.56%333.47M47.33%382.43M
Contract liabilities 102.08%38.93M37.61%28.9M43.07%29.92M-68.08%26.26M9.95%19.26M1.84%21M39.03%20.91M348.09%82.25M-29.29%17.52M-11.52%20.62M
Advance receipts 7.03%1.87M-7.07%1.1M-96.72%959.68K-96.52%1.01M-94.02%1.75M-95.96%1.19M-19.78%29.29M-21.06%29.02M1,836.34%29.18M1,014.97%29.39M
Salaries payable -4.56%31.62M-22.64%32.04M-14.92%65.06M-31.43%74.49M-4.99%33.14M60.95%41.42M7.25%76.46M28.54%108.63M-11.04%34.88M-39.68%25.73M
Taxs payable -59.30%22.45M-57.59%14.82M-7.47%40.58M20.81%67.08M2.27%55.16M-19.51%34.93M-21.17%43.85M76.25%55.53M75.81%53.93M50.98%43.4M
Other payable (including interest and dividends) -19.82%670.85M26.94%1.46B29.97%947.38M7.09%866.16M26.11%836.68M74.20%1.15B11.15%728.93M21.96%808.79M8.82%663.45M-24.55%658.32M
-Interest payable -42.58%15.25M-52.43%6.88M-79.94%501.11K20.74%37.45M24.55%26.55M24.61%14.46M24.62%2.5M99.93%31.01M100.03%21.32M100.00%11.61M
-Dividend payable 12,735.28%665.7K112.23%717.54M0.00%5.19K0.00%5.19K0.00%5.19K6,518,590.16%338.09M0.00%5.19K0.00%5.19K0.00%5.19K-100.00%5.19K
-Other payable -19.16%654.94M-7.92%731.37M30.35%946.87M6.55%828.71M26.16%810.12M22.82%794.26M11.11%726.43M20.10%777.77M7.20%642.12M1.21%646.71M
Non current liabilities due within one year -99.06%22.42M-99.11%20.96M-99.22%18.24M12,691.29%2.33B13,206.92%2.38B11,655.86%2.37B11,102.90%2.35B-28.24%18.23M-18.92%17.91M-10.58%20.13M
Other current liabilities 101.56%4.83M15,355.26%403.62M15,128.22%403.72M-69.32%3.27M5.49%2.39M-2.07%2.61M37.79%2.65M366.16%10.67M-23.22%2.27M-5.01%2.67M
Total current liabilities -47.85%2.36B-27.20%3.52B-20.40%3.47B101.67%4.47B158.63%4.52B186.60%4.84B171.72%4.36B52.18%2.22B30.27%1.75B2.89%1.69B
Current liabilities
Bonds payable --994.72M--994.23M--------------------4.15%2.3B4.39%2.28B4.60%2.26B
Deferred tax liabilities 138.92%30.64M80.43%29.38M65.50%29.13M15.26%30.03M104.64%12.82M-20.23%16.28M-21.36%17.6M7.65%26.06M-88.13%6.27M46.84%20.41M
Long term deferred income -16.04%229.48M-11.93%234.84M-13.06%240.7M-12.15%247.38M-5.81%273.33M-10.59%266.65M-8.10%276.87M-10.28%281.6M-4.75%290.19M-8.05%298.24M
Lease liabilities 2.85%22.97M5.68%21.82M-8.83%19.15M22.45%21.49M9.03%22.34M-19.05%20.65M-17.18%21.01M-24.94%17.55M-5.68%20.48M14.52%25.51M
Total non current liabilities 314.22%1.28B321.72%1.28B-8.40%288.99M-88.63%298.9M-88.13%308.49M-88.34%303.59M-87.80%315.48M2.16%2.63B1.29%2.6B3.27%2.6B
Total liabilities -24.72%3.64B-6.58%4.8B-19.60%3.76B-1.60%4.77B11.12%4.83B19.78%5.14B11.63%4.68B20.24%4.84B11.25%4.35B3.12%4.29B
Shareholders equity
Paid-in capital 2.81%1.2B2.82%1.2B6.70%1.24B0.46%1.17B0.01%1.16B0.00%1.16B0.00%1.16B0.00%1.16B0.00%1.16B0.00%1.16B
Other equity instruments -------------3.14%542.29M-0.07%559.65M-0.04%559.85M-0.03%559.86M-0.03%559.87M-0.00%560.05M-0.00%560.05M
Capital reserve funds 22.82%4.85B22.90%4.85B40.12%5.53B2.24%4.03B0.13%3.95B0.16%3.95B-0.84%3.95B-0.84%3.95B-0.74%3.94B-0.84%3.94B
Surplus reserve funds 5.79%2.49B5.80%2.49B5.80%2.49B5.80%2.49B8.03%2.35B8.29%2.35B8.33%2.35B8.33%2.35B10.53%2.18B10.26%2.17B
Retained profit 3.01%19.91B0.45%19.2B3.44%19.53B5.41%19.38B9.41%19.33B10.94%19.12B10.19%18.88B7.71%18.39B2.79%17.67B4.72%17.23B
Less:Treasury stock --------26.31%720.07M26.31%720.07M12.72%620.05M26.85%570.07M42.51%570.07M42.51%570.07M37.50%550.06M12.34%449.41M
Other composite income 80.89%553.58M79.98%617M113.93%455.99M62.35%314.7M-4.15%306.04M14.31%342.81M-14.94%213.15M-38.08%193.84M30.81%319.28M37.29%299.91M
Shareholders equity without minority interests 7.25%29B5.37%28.36B7.46%28.52B4.52%27.21B6.96%27.04B8.00%26.91B6.78%26.54B4.72%26.03B2.36%25.28B4.08%24.92B
Minority interests -12.54%261.78M-8.69%268.67M-10.13%277M-5.12%288.01M4.31%299.3M6.66%294.25M76.18%308.22M69.33%303.54M56.94%286.95M49.15%275.88M
Total shareholder equity 7.03%29.26B5.21%28.62B7.26%28.8B4.41%27.5B6.93%27.34B7.98%27.21B7.27%26.85B5.19%26.34B2.76%25.57B4.43%25.19B
Total liabilityies and equity 2.26%32.9B3.34%33.42B3.27%32.56B3.48%32.27B7.54%32.17B9.70%32.34B7.89%31.53B7.27%31.18B3.91%29.91B4.24%29.48B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhongzhun Certified Public Accountants (Special General Partnership)------Zhongzhun Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data